Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated significant weight loss effects in clinical trials, with participants losing up to 15% of body weight over 68 weeks. Ohio patients seeking this therapy now have direct access through PlexusDx, which offers compounded semaglutide injections without the barriers of traditional insurance coverage or lengthy waiting lists.

Why Semaglutide Access in Ohio Has Changed

For years, Ohio residents pursuing semaglutide weight loss therapy faced limited options: they either needed to qualify for insurance coverage, find an in-network prescriber, or travel long distances for treatment. PlexusDx has eliminated these obstacles by operating a direct-to-patient model that requires no insurance, no membership fees, and no referral networks. This shift represents a fundamental change in how Ohioans can access precision weight management medications.

The medication works by activating GLP-1 receptors in the brain and pancreas, which regulate hunger signals and blood sugar control. Because compounded semaglutide from licensed 503A pharmacies meets the same quality and safety standards as brand versions, patients receive identical therapeutic benefits at a fraction of the traditional cost. PlexusDx sources all compounds from licensed 503A facilities, ensuring pharmaceutical-grade purity and potency.

How to Start Semaglutide Treatment in Ohio

The enrollment process through PlexusDx requires three simple steps: complete an online health questionnaire, receive a consultation with a licensed medical provider via secure telehealth, and obtain a prescription that is sent directly to a licensed 503A compounding pharmacy. Once approved, patients receive their first shipment within 3–5 business days. This streamlined approach eliminates waiting room visits and insurance pre-authorization delays that typically slow treatment initiation.

Ohio patients do not need an existing relationship with a doctor to begin semaglutide therapy through PlexusDx. The company's medical team evaluates eligibility based on body mass index (BMI), metabolic health markers, and medical history. Most candidates approved for treatment can start their first injection within one week of initial consultation, making it one of the fastest pathways to semaglutide access in the state.

Semaglutide Injection Pricing and Payment Options in Ohio

PlexusDx offers compounded semaglutide injections starting at $149 per month, with no flat per-compound pricing increases. This flat-rate structure means patients' monthly cost remains stable whether they are titrating upward or maintaining a therapeutic dose. The company accepts all major payment methods, including HSA and FSA accounts, which can further reduce the effective cost for Ohio residents with these benefit plans.

Unlike traditional pharmacies that charge per dose, PlexusDx applies a single monthly rate that covers compounding, pharmacy dispensing, shipping, and clinical support. There are no hidden enrollment fees, membership dues, or surprise charges. For Ohio patients on a budget, the Microdose GLP-1 Protocol starts at $129 per month and provides a lower-dose entry point for those beginning their weight loss journey.

Personalized Treatment Through Genetic Testing

PlexusDx offers an optional Precision Peptide Genetic Test ($99 add-on after the first month) that analyzes 14 metabolic pathways and 150+ genetic insights to identify how an individual's DNA influences semaglutide response. The test examines key variants in the GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) genes, which directly affect appetite regulation and weight loss outcomes. This genetic profiling allows medical providers to optimize medication selection and dosing strategy for each Ohio patient.

Understanding your genetic predispositions toward GLP-1 responsiveness can guide decisions about whether semaglutide alone, or a combination therapy like GLP-Squared (semaglutide plus tirzepatide), may produce faster results. Patients with specific genetic markers may experience accelerated weight loss or require lower doses to reach optimal satiety, reducing side effects and improving long-term adherence. The Precision Peptide Genetic Test transforms treatment from a one-size-fits-all approach into a truly personalized protocol.

Supporting Your Semaglutide Journey in Ohio

Beyond the injection itself, PlexusDx provides ongoing clinical support to Ohio patients managing weight loss on semaglutide. Patients receive guidance on dose titration, management of common side effects like nausea or appetite suppression, and strategies to optimize results through nutrition and movement. The telehealth model ensures patients can reach their care team from anywhere in Ohio without scheduling delays.

Many patients notice gradual improvements in appetite control within the first two weeks of semaglutide therapy, with measurable weight loss typically beginning in weeks 3–4. PlexusDx encourages patients to track progress through monthly check-ins and adjustments. If after one month a patient wishes to explore combination therapy or switch to oral tirzepatide, the medical team can facilitate that transition without interrupting continuity of care.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I get semaglutide in Ohio without seeing my current doctor?

Yes. PlexusDx does not require referrals or existing provider relationships. Ohio residents can enroll through the online platform, consult with PlexusDx medical providers via telehealth, and receive a prescription within days—all without contacting their primary care physician.

What percentage of weight loss can I expect from semaglutide?

Clinical trials show patients on semaglutide lose an average of 10–15% of body weight over 68 weeks. Individual results vary based on genetics, lifestyle, and adherence; the Precision Peptide Genetic Test can help predict your likely response by identifying genetic factors that influence satiety and metabolism.

Is compounded semaglutide from PlexusDx the same as the brand-name version?

Compounded semaglutide from licensed 503A pharmacies contains the identical active compound and meets the same purity and potency standards as brand medications. The main difference is cost: PlexusDx compounded semaglutide starts at $149/mo versus $900–$1,300/mo for brand-name products.

What are the most common side effects of semaglutide?

The most frequently reported side effects are nausea, vomiting, constipation, and loss of appetite—most mild and temporary. Serious adverse events are rare when prescribed appropriately. PlexusDx medical staff monitor patients at each check-in and adjust doses or recommend lifestyle changes to minimize discomfort while maintaining therapeutic benefit.

How does the Precision Peptide Genetic Test improve my semaglutide results?

The test identifies your genetic predispositions related to GLP-1 and GIPR signaling, FTO-driven appetite patterns, and MC4R satiety responsiveness. These insights allow PlexusDx providers to predict whether you'll respond best to semaglutide alone, require higher doses, or benefit more from a dual-compound option like GLP-Squared.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves